Archives of Dermatological Research

, Volume 284, Supplement 1, pp S42–S43 | Cite as

Future modalities

  • M. W. Greaves


Public Health Future Modality 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Brody I (1984) Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris. J Invest Dermatol 82: 460–464Google Scholar
  2. 2.
    De Paulis A, Cirillo R, Ciccarelli A, Condorelli M, Marone G (1991) FK506, a potent novel inhibitor of the release of pro-inflammatory mediators from human FceRI+ cells. J Immunol 146: 2374–2381Google Scholar
  3. 3.
    Elias J, Boss E, Kaplan AP (1986) Studies of the cellular infiltrate of chronic idiopathic urticaria. Prominence of T-lymphocytes monocytes and mast cells. J Allergy Clin Immunol 78: 914–918Google Scholar
  4. 4.
    Grattan CEH, Francis DM, Slater NGP, Barlow RJ, Greaves MW (1992) Plasmapheresis for severe unremitting chronic urticaria. Lancet 339: 1078–1080Google Scholar
  5. 5.
    Hide M, Francis DM, Grattan CEH, Hakimi J, Chizzionite R, Greaves MW (1992) Demonstration of histamine releasing autoantibodies against the high affinity IgE receptor (FceRI) in chronic urticaria. J Invest Dermatol 98: 514 (Abstract)Google Scholar
  6. 6.
    Holgate ST (1991) The mast cell and its functions in allergic disease. Clin Exp Allergy 21: 11–16Google Scholar
  7. 7.
    Hultsch T, Rodriquez JL, Kaliner MA, Hohman RJ (1990) Cyclosporin A inhibits degranulation of rat basophil leukaemia cells and human basophils. J Immunol 144: 2659–2664Google Scholar
  8. 8.
    Johnson HH, De Oreo GA, Lascheid WP, Mitchell F (1960) Skin histamine levels in chronic atopic dermatitis. J Invest Dermatol 34: 237–238Google Scholar
  9. 9.
    Kaplan AP, Horazokowa Z, Katz SI (1978) Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 61: 350–354Google Scholar
  10. 10.
    Klein LM, Lavker RM, Matis WL, Murphy GF (1989) Degranulation of human mast cells induces an endothelial antigen central to leucocyte adhesion. Proc Natl Acad Sci USA 86: 8972–8976Google Scholar
  11. 11.
    Mihm MC, Soter NA, Dvorak HF, Austen KF (1976) The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67: 305–312Google Scholar
  12. 12.
    Toruniowa B, Jablonska S (1988) Mast cells in the initital stages of psoriasis. Arch Dermatol Res 280: 189–193Google Scholar
  13. 13.
    Triggiani M, Cirillo R, Lichtenstein LM, Marone G (1989) Inhibition of histamine and prostaglandin D2 release from human lung mast cells by cyclosporin A. Int Arch Allergy Appl Immunol 88: 253–255Google Scholar
  14. 14.
    Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF (1991) Human dermal mast cells contain and release tumour necrosis factor alpha which indiced endothelial leucocyte adhesion molecule-1. Pro Natl Acad Sci USA 88: 4420–4424Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • M. W. Greaves
    • 1
  1. 1.St. John's Institute of DermatologySt. Thomas's HospitalLondonUK

Personalised recommendations